Rousselot STABICAPS™, the proven solution for more stable soft gels
Product description
When
manufacturing soft gels, nutra- and pharmaceutical manufacturers sometimes
experience shell cross-linking leading to stability issues. With StabiCaps,
such stability issues can be overcome. Building
on its extensive in-house research, Rousselot has developed a range of gelatins
with superior performance in terms of soft gel stability and resistance to
crosslinking; this patented technology is commercialized under the name
StabiCaps and has been specifically designed to offer a low viscosity profile
and pH range, both necessary qualities to reduce crosslinking in soft capsule
formulation.
StabiCaps is the perfect solution for the most reactive fills, offering:
- Reduced maturation time and faster drying time, improving production efficiency
- Perfect protection of active ingredients
- Optimal behavior in the presence of cross-linkers- Optimal shell stability and shelf-life
- Optimal dissolution and API releaseMore on www.rousselot.com/functional
Read more
StabiCaps is the perfect solution for the most reactive fills, offering:
- Reduced maturation time and faster drying time, improving production efficiency
- Perfect protection of active ingredients
- Optimal behavior in the presence of cross-linkers- Optimal shell stability and shelf-life
- Optimal dissolution and API releaseMore on www.rousselot.com/functional
Specifications
Categories | Pharmaceutical Ingredients |
---|---|
Sales markets | Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America |
End-Use Categories | Pharmaceutical |
Certifications | Halal; Kosher |
Rousselot STABICAPS™, the proven solution for more stable soft gels